Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 30, 2020
Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastasesKazuto Harada, Hyunsoo Hwang, Xuemei Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal CancerKazuki Sudo, Xuemei Wang, Lianchun Xiao, et al.
The Annals of Thoracic Surgery|May 19, 2019
Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III AdenocarcinomaKyle G Mitchell, Naruhiko Ikoma, David B Nelson, et al.
The Annals of Thoracic Surgery|December 9, 2021
Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell CancersNicolas Zhou, Wayne L Hofstetter, , et al.
Oncology|July 7, 2017
101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative TherapyDilsa Mizrak Kaya, Xuemei Wang, Kazuto Harada, et al.
British Journal of Cancer|July 21, 2017
Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patientsRoopma Wadhwa, Xuemei Wang, Veerabhadran Baladandayuthapani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2020
Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified SettingJeffrey S Morris, Rajyalakshmi Luthra, Yusha Liu, et al.
British Journal of Cancer|December 14, 2017
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trialYusuke Shimodaira, Rebecca S Slack, Kazuto Harada, et al.
Cancer Cell|March 26, 2019
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal CancerWenting Liao, Michael J Overman, Adam T Boutin, et al.
Pageof 17